Development of FIV-specific cytolytic T-lymphocyte responses in cats upon immunisation with FIV vaccines.
Vaccine protection has been achieved in cats against experimental infection with feline immunodeficiency virus (FIV). Such protection has been attributed to FIV-specific humoral immunity, as well as cellular immunity of unknown mechanism(s). Since cell-mediated immunity plays a crucial role in the clearance of viral infections, this study evaluated the role of FIV-specific CTL in vaccine prophylaxis. Cats were immunised with inactivated FIV vaccines, reported to have > 90% vaccine efficacy. Significant levels of specific CTL activity were detected following the third immunisation. CTL activity persisted for several months and could be enhanced through a booster immunisation. The levels of CTL activity were comparable to those induced by a recombinant canarypoxvirus based FIV vaccine. These results suggest a possible role for CTL-mediated immunity in vaccine protection against FIV infection in cats.
Tellier
M C
MC
Department of Pathobiology, School of Veterinary Medicine, University of Florida, Gainesville 32611, USA.
Soos
J
J
Pu
R
R
Pollock
D
D
Yamamoto
J K
JK
D000818:Animals; D000956:Antigens, Viral; D016516:CD4-CD8 Ratio; D002415:Cats / Q000276:immunology*; D003602:Cytotoxicity, Immunologic; D016181:Feline Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D007111:Immunity, Cellular; D007114:Immunization; D016089:Immunodeficiency Virus, Feline / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*; D014765:Viral Vaccines
D000956:Antigens, Viral; D014765:Viral Vaccines